While hyperlipidemia treatments have hesitated, hypertension and antithrombotic treatments are showing contradict performance

Among cardiovascular drugs encountered contradict situations. Although outpatient prescriptions of hypertension treatments (ARB type) increased narrowly, hyperlipidemia and antithrombotic treatments drew significant increase curves in the first quarter of the year.

According to the UBIST data on the 20^th, it is estimated that outpatient prescriptions of ARB(Angiotensin II Receptor Blocker)-typ...